95 related articles for article (PubMed ID: 4056844)
1. Detorubicin--an active anthracycline in untreated metastatic melanoma.
Chawla SP; Legha SS; Benjamin RS
J Clin Oncol; 1985 Nov; 3(11):1529-34. PubMed ID: 4056844
[TBL] [Abstract][Full Text] [Related]
2. Clinical study of detorubicin. EORTC Clinical Screening Group.
Recent Results Cancer Res; 1980; 74():184-91. PubMed ID: 7444139
[TBL] [Abstract][Full Text] [Related]
3. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of oral 4-demethoxydaunorubicin in previously treated (except anthracyclines) metastatic breast cancer patients.
Kolarić K; Mechl Z; Potrebica V; Sopkova B
Oncology; 1987; 44(2):82-6. PubMed ID: 3472133
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.
Bastholt L; Dalmark M
Cancer Treat Rep; 1987 May; 71(5):451-4. PubMed ID: 3471329
[TBL] [Abstract][Full Text] [Related]
6. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of idarubicin in patients with advanced lymphoma.
Gillies H; Liang R; Rogers H; Harper P; Parapia L; Cox G; Johnson S
Cancer Chemother Pharmacol; 1988; 21(3):261-4. PubMed ID: 3162850
[TBL] [Abstract][Full Text] [Related]
8. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
Cancer Treat Rep; 1986 Jul; 70(7):911-2. PubMed ID: 3459575
[No Abstract] [Full Text] [Related]
9. Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
Toffoli G; Sorio R; Aita P; Crivellari D; Corona G; Bearz A; Robieux I; Colussi AM; Stocco F; Boiocchi M
Clin Cancer Res; 2000 Jun; 6(6):2279-87. PubMed ID: 10873078
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of detorubicin in malignant mesothelioma.
Colbert N; Vannetzel JM; Izrael V; Schlienger M; Milleron B; Blanchon F; Herman D; Akoun G; Roland J; Chatelet F
Cancer; 1985 Nov; 56(9):2170-4. PubMed ID: 3902205
[TBL] [Abstract][Full Text] [Related]
11. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
Warrell RP; Arlin ZA; Kempin SJ; Young CW
Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
[TBL] [Abstract][Full Text] [Related]
12. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
[TBL] [Abstract][Full Text] [Related]
13. The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.
Martoni A; Pacciarini MA; Pannuti F
Drugs Exp Clin Res; 1985; 11(2):127-31. PubMed ID: 3915281
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma.
Chisesi T; Capnist G; de Dominicis E; Dini E
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):681-4. PubMed ID: 3164269
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group.
Shapiro CL; Ervin T; Welles L; Azarnia N; Keating J; Hayes DF
J Clin Oncol; 1999 May; 17(5):1435-41. PubMed ID: 10334528
[TBL] [Abstract][Full Text] [Related]
16. A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors.
Martoni A; Giovannini M; Tomasi L; Camaggi CM; Bellanova B; Monetti N; Rossini G; Tarquinii M; Martini A; Pannuti F
Cancer Chemother Pharmacol; 1984; 12(3):179-82. PubMed ID: 6584236
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of a phase II trial on solid tumors of detorubicin, a new anthracyclin.
Cancer Clin Trials; 1980; 3(2):115-20. PubMed ID: 7428135
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of oral idarubicin in metastatic melanoma.
Martoni A; Pacciarini MA; Piana E; Pannuti F
Chemioterapia; 1986 Dec; 5(6):414-5. PubMed ID: 3467876
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of rubidazone in solid tumors and malignant lymphomas.
Skovsgaard T; Hansen HH; Mouridsen HT; Nissen NI; Pedersen-Bjergaard J
Cancer Treat Rep; 1978 Jul; 62(7):1053-8. PubMed ID: 356967
[TBL] [Abstract][Full Text] [Related]
20. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
